The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Iron Deficiency Anemia Treatment Market Research Report 2025

Global Iron Deficiency Anemia Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1691561

No of Pages : 91

Ask Your Query

Synopsis

People with iron deficiency and mild to moderate anemia are mainly treated with oral iron, and their diets should be improved to eat iron-rich foods. Severe anemia can be treated with oral iron or intravenous iron, as well as a small number of repeated infusions of packed red blood cells. However, intravenous iron supplementation is not recommended during the first trimester.

Global Iron Deficiency Anemia Treatment market is projected to reach US$ 1136.6 million in 2029, increasing from US$ 899.4 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Iron Deficiency Anemia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List)

  •     AdvaCare Pharma
  •     Akorn
  •     Sun Pharmaceutical Industries Ltd.
  •     Akebia Therapeutics, Inc.
  •     Rockwell Medical, Inc.
  •     Vifor Pharma Management Ltd.
  •     Shield Therapeutics
  •     AMAG Pharmaceuticals
  •     Pharmacosmos A/S

Segment by Type

  •     Ferrous Sulfate
  •     Ferrous Gluconate
  •     Ferrous Fumerate
  •     Ferric Hydroxide
  •     Sodium Ferric Gluconate
  •     Iron Carbohydrates
  •     Others

Segment by Application

  •     Hospital Pharmacies
  •     Retail Pharmacies
  •     Online Pharmacies

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

 

The Iron Deficiency Anemia Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

   1.1 Product Overview and Scope of Iron Deficiency Anemia Treatment
    1.2 Iron Deficiency Anemia Treatment Segment by Type
        1.2.1 Global Iron Deficiency Anemia Treatment Market Value Comparison by Type (2023-2029)
        1.2.2 Ferrous Sulfate
        1.2.3 Ferrous Gluconate
        1.2.4 Ferrous Fumerate
        1.2.5 Ferric Hydroxide
        1.2.6 Sodium Ferric Gluconate
        1.2.7 Iron Carbohydrates
        1.2.8 Others
    1.3 Iron Deficiency Anemia Treatment Segment by Application
        1.3.1 Global Iron Deficiency Anemia Treatment Market Value by Application: (2023-2029)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Iron Deficiency Anemia Treatment Market Size Estimates and Forecasts
        1.4.1 Global Iron Deficiency Anemia Treatment Revenue 2018-2029
        1.4.2 Global Iron Deficiency Anemia Treatment Sales 2018-2029
        1.4.3 Global Iron Deficiency Anemia Treatment Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Iron Deficiency Anemia Treatment Market Competition by Manufacturers
    2.1 Global Iron Deficiency Anemia Treatment Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Iron Deficiency Anemia Treatment Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Iron Deficiency Anemia Treatment Average Price by Manufacturers (2018-2023)
    2.4 Global Iron Deficiency Anemia Treatment Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Iron Deficiency Anemia Treatment, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Iron Deficiency Anemia Treatment, Product Type & Application
    2.7 Iron Deficiency Anemia Treatment Market Competitive Situation and Trends
        2.7.1 Iron Deficiency Anemia Treatment Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Iron Deficiency Anemia Treatment Players Market Share by Revenue
        2.7.3 Global Iron Deficiency Anemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Iron Deficiency Anemia Treatment Retrospective Market Scenario by Region
    3.1 Global Iron Deficiency Anemia Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Iron Deficiency Anemia Treatment Global Iron Deficiency Anemia Treatment Sales by Region: 2018-2029
        3.2.1 Global Iron Deficiency Anemia Treatment Sales by Region: 2018-2023
        3.2.2 Global Iron Deficiency Anemia Treatment Sales by Region: 2024-2029
    3.3 Global Iron Deficiency Anemia Treatment Global Iron Deficiency Anemia Treatment Revenue by Region: 2018-2029
        3.3.1 Global Iron Deficiency Anemia Treatment Revenue by Region: 2018-2023
        3.3.2 Global Iron Deficiency Anemia Treatment Revenue by Region: 2024-2029
    3.4 North America Iron Deficiency Anemia Treatment Market Facts & Figures by Country
        3.4.1 North America Iron Deficiency Anemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Iron Deficiency Anemia Treatment Sales by Country (2018-2029)
        3.4.3 North America Iron Deficiency Anemia Treatment Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Iron Deficiency Anemia Treatment Market Facts & Figures by Country
        3.5.1 Europe Iron Deficiency Anemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Iron Deficiency Anemia Treatment Sales by Country (2018-2029)
        3.5.3 Europe Iron Deficiency Anemia Treatment Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Iron Deficiency Anemia Treatment Market Facts & Figures by Country
        3.6.1 Asia Pacific Iron Deficiency Anemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Iron Deficiency Anemia Treatment Sales by Country (2018-2029)
        3.6.3 Asia Pacific Iron Deficiency Anemia Treatment Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Iron Deficiency Anemia Treatment Market Facts & Figures by Country
        3.7.1 Latin America Iron Deficiency Anemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Iron Deficiency Anemia Treatment Sales by Country (2018-2029)
        3.7.3 Latin America Iron Deficiency Anemia Treatment Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Iron Deficiency Anemia Treatment Market Facts & Figures by Country
        3.8.1 Middle East and Africa Iron Deficiency Anemia Treatment Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Iron Deficiency Anemia Treatment Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Iron Deficiency Anemia Treatment Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Iron Deficiency Anemia Treatment Sales by Type (2018-2029)
        4.1.1 Global Iron Deficiency Anemia Treatment Sales by Type (2018-2023)
        4.1.2 Global Iron Deficiency Anemia Treatment Sales by Type (2024-2029)
        4.1.3 Global Iron Deficiency Anemia Treatment Sales Market Share by Type (2018-2029)
    4.2 Global Iron Deficiency Anemia Treatment Revenue by Type (2018-2029)
        4.2.1 Global Iron Deficiency Anemia Treatment Revenue by Type (2018-2023)
        4.2.2 Global Iron Deficiency Anemia Treatment Revenue by Type (2024-2029)
        4.2.3 Global Iron Deficiency Anemia Treatment Revenue Market Share by Type (2018-2029)
    4.3 Global Iron Deficiency Anemia Treatment Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Iron Deficiency Anemia Treatment Sales by Application (2018-2029)
        5.1.1 Global Iron Deficiency Anemia Treatment Sales by Application (2018-2023)
        5.1.2 Global Iron Deficiency Anemia Treatment Sales by Application (2024-2029)
        5.1.3 Global Iron Deficiency Anemia Treatment Sales Market Share by Application (2018-2029)
    5.2 Global Iron Deficiency Anemia Treatment Revenue by Application (2018-2029)
        5.2.1 Global Iron Deficiency Anemia Treatment Revenue by Application (2018-2023)
        5.2.2 Global Iron Deficiency Anemia Treatment Revenue by Application (2024-2029)
        5.2.3 Global Iron Deficiency Anemia Treatment Revenue Market Share by Application (2018-2029)
    5.3 Global Iron Deficiency Anemia Treatment Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 AdvaCare Pharma
        6.1.1 AdvaCare Pharma Corporation Information
        6.1.2 AdvaCare Pharma Description and Business Overview
        6.1.3 AdvaCare Pharma Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 AdvaCare Pharma Iron Deficiency Anemia Treatment Product Portfolio
        6.1.5 AdvaCare Pharma Recent Developments/Updates
    6.2 Akorn
        6.2.1 Akorn Corporation Information
        6.2.2 Akorn Description and Business Overview
        6.2.3 Akorn Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Akorn Iron Deficiency Anemia Treatment Product Portfolio
        6.2.5 Akorn Recent Developments/Updates
    6.3 Sun Pharmaceutical Industries Ltd.
        6.3.1 Sun Pharmaceutical Industries Ltd. Corporation Information
        6.3.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
        6.3.3 Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Sun Pharmaceutical Industries Ltd. Iron Deficiency Anemia Treatment Product Portfolio
        6.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    6.4 Akebia Therapeutics, Inc.
        6.4.1 Akebia Therapeutics, Inc. Corporation Information
        6.4.2 Akebia Therapeutics, Inc. Description and Business Overview
        6.4.3 Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Akebia Therapeutics, Inc. Iron Deficiency Anemia Treatment Product Portfolio
        6.4.5 Akebia Therapeutics, Inc. Recent Developments/Updates
    6.5 Rockwell Medical, Inc.
        6.5.1 Rockwell Medical, Inc. Corporation Information
        6.5.2 Rockwell Medical, Inc. Description and Business Overview
        6.5.3 Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Rockwell Medical, Inc. Iron Deficiency Anemia Treatment Product Portfolio
        6.5.5 Rockwell Medical, Inc. Recent Developments/Updates
    6.6 Vifor Pharma Management Ltd.
        6.6.1 Vifor Pharma Management Ltd. Corporation Information
        6.6.2 Vifor Pharma Management Ltd. Description and Business Overview
        6.6.3 Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Vifor Pharma Management Ltd. Iron Deficiency Anemia Treatment Product Portfolio
        6.6.5 Vifor Pharma Management Ltd. Recent Developments/Updates
    6.7 Shield Therapeutics
        6.6.1 Shield Therapeutics Corporation Information
        6.6.2 Shield Therapeutics Description and Business Overview
        6.6.3 Shield Therapeutics Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Shield Therapeutics Iron Deficiency Anemia Treatment Product Portfolio
        6.7.5 Shield Therapeutics Recent Developments/Updates
    6.8 AMAG Pharmaceuticals
        6.8.1 AMAG Pharmaceuticals Corporation Information
        6.8.2 AMAG Pharmaceuticals Description and Business Overview
        6.8.3 AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 AMAG Pharmaceuticals Iron Deficiency Anemia Treatment Product Portfolio
        6.8.5 AMAG Pharmaceuticals Recent Developments/Updates
    6.9 Pharmacosmos A/S
        6.9.1 Pharmacosmos A/S Corporation Information
        6.9.2 Pharmacosmos A/S Description and Business Overview
        6.9.3 Pharmacosmos A/S Iron Deficiency Anemia Treatment Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Pharmacosmos A/S Iron Deficiency Anemia Treatment Product Portfolio
        6.9.5 Pharmacosmos A/S Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Iron Deficiency Anemia Treatment Industry Chain Analysis
    7.2 Iron Deficiency Anemia Treatment Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Iron Deficiency Anemia Treatment Production Mode & Process
    7.4 Iron Deficiency Anemia Treatment Sales and Marketing
        7.4.1 Iron Deficiency Anemia Treatment Sales Channels
        7.4.2 Iron Deficiency Anemia Treatment Distributors
    7.5 Iron Deficiency Anemia Treatment Customers

 8 Iron Deficiency Anemia Treatment Market Dynamics
    8.1 Iron Deficiency Anemia Treatment Industry Trends
    8.2 Iron Deficiency Anemia Treatment Market Drivers
    8.3 Iron Deficiency Anemia Treatment Market Challenges
    8.4 Iron Deficiency Anemia Treatment Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock